Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy

• Marion Adelfinger ,

  Contributed equally to this work with: Marion Adelfinger, Ivaylo Gentschev, Julio Grimm de Guibert

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Ivaylo Gentschev ,

  Contributed equally to this work with: Marion Adelfinger, Ivaylo Gentschev, Julio Grimm de Guibert

  Affiliations Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany, Genelux Corporation, San Diego Science Center, San Diego, California, United States of America

  ⨯
• Julio Grimm de Guibert ,

  Contributed equally to this work with: Marion Adelfinger, Ivaylo Gentschev, Julio Grimm de Guibert

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Stephanie Weibel,

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Johanna Langbein-Laugwitz,

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Barbara Härtl,

  Affiliations Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany, Genelux GmbH, Bernried, Germany

  ⨯
• Hugo Murua Escobar,

  Affiliations Small Animal Clinic, University of Veterinary Medicine, Hannover, Germany, Division of Medicine Clinic III, Hematology, Oncology and Palliative Medicine University of Rostock, Rostock, Germany

  ⨯
• Ingo Nolte,

  Affiliation Small Animal Clinic, University of Veterinary Medicine, Hannover, Germany

  ⨯
• Nanhai G. Chen,

  Affiliations Genelux Corporation, San Diego Science Center, San Diego, California, United States of America, Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Richard J. Aguilar,

  Affiliation Genelux Corporation, San Diego Science Center, San Diego, California, United States of America

  ⨯
• Yong A. Yu,

  Affiliations Genelux Corporation, San Diego Science Center, San Diego, California, United States of America, Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Qian Zhang,

  Affiliations Genelux Corporation, San Diego Science Center, San Diego, California, United States of America, Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Alexa Frentzen,

  Affiliation Genelux Corporation, San Diego Science Center, San Diego, California, United States of America

  ⨯
• Aladar A. Szalay

  * E-mail: aaszalay@genelux.com

  Affiliations Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany, Genelux Corporation, San Diego Science Center, San Diego, California, United States of America, Division of Medicine Clinic III, Hematology, Oncology and Palliative Medicine University of Rostock, Rostock, Germany, Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America, Rudolf Virchow Center for Experimental Biomedicine, University of Wuerzburg, Wuerzburg, Germany, Institute for Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany

  ⨯